Precision BioSciences's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Precision BioSciences is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $-2.43. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 13.12M	$ 19.79M	$ 8.78M	$ 10.60M	$ 7.36M
Gross Profit	$ 13.12M	$ 19.79M	$ 8.78M	$ 10.60M	-
EBIT	$ -11.53M	$ -11.34M	$ -24.54M	$ -29.94M	$ -23.54M
EBITDA	$ -9.57M	$ -9.00M	$ -22.14M	$ -37.74M	$ -21.29M
Net Income Common Stockholders	$ -8.08M	$ -11.89M	$ -25.06M	$ -28.49M	$ -23.95M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 122.23M	$ 137.79M	$ 158.13M	$ 189.58M	$ 212.05M
Total Assets	$ 164.34M	$ 181.70M	$ 204.50M	$ 238.17M	$ 271.73M
Total Debt	$ 23.86M	$ 27.99M	$ 26.60M	$ 27.04M	$ 27.46M
Net Debt	$ -98.37M	$ -109.81M	$ -131.53M	$ -162.54M	$ -184.59M
Total Liabilities	$ 135.28M	$ 147.66M	$ 164.32M	$ 177.74M	$ 187.35M
Stockholders Equity	$ 29.06M	$ 34.04M	$ 40.18M	$ 60.43M	$ 84.38M
Cash Flow	-
Free Cash Flow	$ -23.48M	$ -22.14M	$ -31.98M	$ -22.48M	$ 28.10M
Operating Cash Flow	$ -23.09M	$ -21.13M	$ -31.46M	$ -21.84M	$ 29.19M
Investing Cash Flow	$ 7.56M	$ -1.06M	$ -721.00K	$ -632.00K	$ -1.09M
Financing Cash Flow	$ -34.00K	$ 1.85M	$ 741.00K	-	$ -180.00K

Currency in USD

Precision BioSciences Earnings and Revenue History

Income Statement >

Precision BioSciences Debt to Assets

Balance Sheet >

Precision BioSciences Cash Flow

Cash Flow >

Precision BioSciences Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing